Philips and MEDSI to Enter New Healthcare Technology Partnership in Russia

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA) and MEDSI, Russia's largest network of private clinics, announced a strategic partnership to develop a clinical network aimed at providing efficient medical care in Russia. MEDSI president Alexey Chupin, and Peter Vullinghs, CEO of Philips in Russia and the Commonwealth of Independent States (CIS) have signed a Memorandum of Understanding (MOU) in Davos during a ceremony attended by Vladimir Evtushenkov, Chairman of the Board of Directors of Sistema Joint-Stock Financial Corporation (JSFC), and Frans van Houten, CEO of Royal Philips.

Philips and MEDSI, a leading provider of patient-centered quality care in Russia, will cooperate to achieve operational excellence at MEDSI's healthcare facilities. This new partnership goes beyond the traditional supply of innovative medical equipment and advanced technologies. It includes the access to Philips' international expertise in hospital management and the company’s conceptual understanding of hospital settings. The financial details of the partnership will not be disclosed.

The comprehensive multi-year partnership will provide MEDSI hospitals with guaranteed affordable access to the latest Philips healthcare equipment and technology, enabling MEDSI to focus on the delivery of high quality care. Philips will manage the technology and its operational performance, and provide performance management consultancy services in order to support enhanced quality of care. This business model will allow the hospitals involved to optimize their infrastructure management, patient flows and processes, and receive continuous training as well as regular system and software upgrades from Philips.

"Philips will be one of the first companies in Russia to manage such a large-scale project by providing a unified hospital solution that includes everything from design, equipment, service, patient flow management, clinical performance improvement and overall hospital management," said Peter Vullinghs. "We are extremely delighted to enter into this innovative partnership with MEDSI - the leading private healthcare provider in Russia and a very effective and dynamic organization."

"Signing of this cooperation agreement is an important step forward in MEDSI's business development and closely corresponds to our strategy of extending our clinical network and enhancing the quality of our medical services," said Alexey Chupin. "We have already achieved some good results towards this goal, and in partnership with Philips we believe we can do even more to turn our hospitals into high-tech medical institutions, where patients will receive high quality effective care based on early diagnostics in accordance with the best international quality standards."

Philips and MEDSI will cooperate in the areas of hospital renovation, full technical re-equipment of a MEDSI Clinical Hospital in Moscow's suburban area, and the building of a new clinical diagnostics center for children and adults, including a short-term in-patient hospital and children's clinical hospital. The partnership also extends to a multi-profile clinical diagnostics center for children and adults with a daytime in-patient hospital, which will be built as part of MEDSI's Clinical Hospital on Michurinsky Avenue, Moscow. It is envisaged that this complex will become a flagship hospital for the MEDSI network, showcasing the latest trends and conceptual ideas in organizing and operating a hospital.

Related news articles:

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2012 sales of EUR 24.8 billion and employs approximately 114,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare.

About MEDSI Group of Companies
The MEDSI Group of Companies is a leading national provider of medical and healthcare services in Moscow and other regions. Its network comprises 30 medical centers, of which 19 are in Moscow and the surrounding region and 11 in other parts of Russia. The Group's facilities include a clinical and diagnostic center at Belorusskaya, MEDSI International Clinic, two children's clinics and a network of fitness and wellness clubs.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...